8-K: NewLake Capital Partners Reports Solid Year-End Results, Boosts Dividend Despite Cannabis Sector Challenges
Earnings Release
NewLake Capital Partners announces its fourth quarter and full-year 2024 financial results, showcasing revenue growth and increased dividends despite a challenging environment for the cannabis industry.
Summary
- NewLake Capital Partners reported its financial results for Q4 and full year 2024.
- Full year revenue reached $50.1 million, a 6.0% increase year-over-year.
- Full year net income attributable to common stockholders was $26.1 million.
- Funds From Operations (FFO) for the full year totaled $41.3 million, up 5.1% year-over-year.
- Adjusted Funds From Operations (AFFO) for the full year was $43.7 million, a 7.5% increase year-over-year.
- The company declared a first quarter 2025 dividend of $0.43 per share.
- Cash and cash equivalents as of December 31, 2024, were $20.2 million, with $11.0 million committed to future improvements.
- The company extended its stock repurchase program through December 31, 2026.
- NewLake entered into Equity Distribution Agreements (EDAs) for a $50 million At The Market Program.
- During 2024, the company purchased a cultivation facility in Connecticut for $4.0 million and committed to $12.0 million in improvements.
- The company funded $15.1 million of improvement allowances across four cultivation facilities during the year.
- On February 19, 2025, NewLake purchased a dispensary in Ohio for $276 thousand and committed to $705 thousand for improvements.
- Total liquidity as of December 31, 2024, was $102.6 million, including availability under the revolving credit facility.
- Gross real estate assets totaled $431.4 million.
- The debt to total gross assets ratio was 1.6%, with a debt service coverage ratio of approximately 32.3x.
- No debt maturities are scheduled until May 2027.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive. While the company shows year-over-year growth and increased dividends, there are concerns about tenant financial health and a decrease in Q4 revenue and net income. The company's strong liquidity and low debt provide some reassurance.
Positives
- NewLake Capital Partners achieved year-over-year revenue growth of 6.0%, reaching $50.1 million for the full year 2024.
- Net income attributable to common stockholders increased to $26.1 million for the full year 2024.
- The company increased its annual dividend by 8.3% to $1.70 per share, demonstrating a commitment to shareholder value.
- Adjusted Funds From Operations (AFFO) grew by 7.5% year-over-year, reaching $43.7 million for the full year 2024.
- The company maintains a strong liquidity position with $102.6 million available as of December 31, 2024.
- The company's debt to total gross assets ratio is low at 1.6%, indicating a conservative capital structure.
- The company's debt service coverage ratio is high at approximately 32.3x.
- The company has no debt maturities until May 2027.
- The company's general and administrative expense ratio is low at 1.4%.
Negatives
- Fourth quarter revenue decreased by approximately 3.9% year-over-year, totaling $12.5 million compared to $13.0 million in 2023.
- Net income attributable to common stockholders for the fourth quarter decreased to $6.0 million from $7.0 million in the same period of 2023.
- Funds From Operations (FFO) for the fourth quarter decreased by approximately 6.9% year-over-year, totaling $9.9 million compared to $10.7 million.
- Revolutionary Clinics paid approximately 50% of its contractual rent from June 2024 through December 2024 and entered into receivership on December 13, 2024.
- Calypso Enterprises did not pay contractual rent from September 2024 through December 2024, and the company applied $1.2 million from a rent escrow deposit to cover the outstanding rent.
- The company recorded an impairment loss on warrants of $522 thousand due to Revolutionary Clinics' receivership status.
Risks
- The cannabis industry faces ongoing challenges that could impact NewLake's tenants and their ability to pay rent.
- The receivership of Revolutionary Clinics and the rent default by Calypso Enterprises highlight the risk of tenant financial distress.
- The company's reliance on a limited number of tenants concentrates risk within the portfolio.
- Changes in cannabis regulations at the state and federal levels could impact the industry and NewLake's business.
- The company's At The Market (ATM) equity program could dilute existing shareholders if utilized.
- The company's stock repurchase program may not be effective in increasing shareholder value.
- The company's forward-looking statements are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict.
Future Outlook
The company anticipates continued growth in the cannabis industry and aims to deliver value to shareholders through strategic investments and dividend increases.
Management Comments
- Anthony Coniglio, NewLake's President and Chief Executive Officer, stated that the company delivered year-over-year growth across all key financial metrics despite a challenging year for the cannabis industry.
- Anthony Coniglio highlighted the increase in the annual dividend to $1.70 per share, an 8.3% increase over 2023, underscoring the company's commitment to delivering value to shareholders.
- Anthony Coniglio attributed the results to the strength of the company's underwriting process and the capabilities of its team in proactively managing portfolio risks.
Industry Context
NewLake Capital Partners operates in the cannabis real estate sector, providing capital to state-licensed cannabis operators. The industry is experiencing growth, but also faces regulatory uncertainty and financial challenges for some operators. NewLake's focus on triple-net leases and strategic portfolio management aims to mitigate risks associated with the industry.
Comparison to Industry Standards
- NewLake's dividend yield of 10.8% is higher than non-cannabis REIT peers, which average 5.4%.
- NewLake's AFFO multiple of 7.7x is lower than non-cannabis REIT peers, which average 13.8x, suggesting it may be undervalued.
- NewLake's debt to equity ratio of 1.9% is significantly lower than non-cannabis REIT peers, which average 76.4%, indicating a more conservative capital structure.
- Compared to Innovative Industrial Properties (IIPR), a major competitor, NewLake has a similar dividend yield (10.8% vs 10.7%) but a lower AFFO multiple (7.7x vs 8.0x).
- NewLake's price to book ratio of 0.8x is lower than IIPR's 1.1x, suggesting a potentially more attractive valuation.
Stakeholder Impact
- Shareholders will benefit from the increased annual dividend of $1.70 per share.
- Tenants may face increased scrutiny due to the financial challenges experienced by some operators.
- Employees are likely to be affected by the company's strategic decisions regarding portfolio management and investment activity.
- The company's financial performance impacts its ability to access capital and maintain relationships with creditors.
Next Steps
- Management will host a conference call and webcast on March 6, 2025, to discuss the financial results.
- The company will continue to manage its portfolio and address tenant issues.
- The company will continue to evaluate investment opportunities in the cannabis real estate sector.
- The company will pay the first quarter 2025 dividend on April 15, 2025, to stockholders of record as of March 31, 2025.
Key Dates
| Date | Description |
|---|---|
| December 20, 2021 | Acquired cultivation facility in Chaffee, Missouri. |
| June 30, 2022 | Acquired cultivation facility in Pottsville, Pennsylvania. |
| November 4, 2022 | Acquired dispensary in Wapakoneta, Ohio. |
| January 3, 2024 | Paid final installment on loan for Chaffee, Missouri cultivation facility. |
| May 7, 2024 | Purchased a cultivation facility in Connecticut. |
| June 10, 2024 | Entered into an equity distribution agreement (EDA) and established the Companys At The Market (ATM Program). |
| November 19, 2024 | Board of directors authorized an amendment to extend the stock repurchase program through December 31, 2026. |
| November 20, 2024 | Entered into a separate equity distribution agreement (together with the EDA, collectively, the EDAs) related to its ATM Program to add an additional sales agent. |
| December 12, 2024 | Board of directors declared a fourth quarter 2024 cash dividend of $0.43 per share of common stock. |
| December 13, 2024 | Revolutionary Clinics entered into receivership. |
| December 31, 2024 | End of the fourth quarter and full year 2024. |
| January 15, 2025 | Fourth quarter 2024 dividend was paid. |
| February 19, 2025 | Purchased a dispensary in Ohio. |
| March 4, 2025 | Board of directors declared a first quarter 2025 cash dividend of $0.43 per share of common stock. |
| March 5, 2025 | Date of the earnings release. |
| March 6, 2025 | Conference call and webcast to discuss fourth quarter and full year 2024 financial results. |
| March 20, 2025 | Dial-in replay of the earnings call available until this date. |
| March 31, 2025 | Stockholders of record date for first quarter 2025 dividend. |
| April 15, 2025 | Payment date for first quarter 2025 dividend. |
| December 31, 2026 | End date of the extended stock repurchase program. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.